Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
2.7 Network pharmacology Compound information was obtained through PubChem
The regulatory picture is unusual and worth stating plainly: the afamelanotide molecule is FDA-approved but only as SCENESSE, a 16 mg controlled-release bioresorbable implant placed by a trained clinician to reduce phototoxic pain in adults with erythropoietic protoporphyria (EPP), a rare light-sensitivity disorder [1]
Red Fox Peptides was built specifically for the Canadian research community
If your dose is 5 units or fewer, a 50-unit syringe can help you measure more accurately
US$ 23.06
US$ 21.50
US$ 20.30
US$ 21.57
US$ 26.30
